DEPARTMENT OF ONCOLOGY

It is a fact that oncology patients are a special treatment group , as the pressing time, the choice of the most appropriate treatment (there is no luxury of many experiments) and the high cost of management, force them to make quick and right decisions.

The continuous effort and cooperation, worldwide, of scientists of various disciplines, has been judged effective and the results are visible in several cases of diseases of this category. 

The ability of genetic identification (identification of mutations) of the tumor and the genetic analysis, contributed to the more accurate diagnosis and prognosis of the disease, as well as to the best individualized treatment.

“Analysis “, in order to provide as many diagnostic data to oncologists about their patients, created the department of oncology diagnostic. This department operates in collaboration with others of the company (molecular biology, genetics, flow cytometry, pharmacodynamics) as well as with the use of modern bioinformatics processing tools, that it owns.